CEACAM5 and cancer: First, Aggarwal et al. observed that the performance of cancer prognosis among metastatic CRC patients can be distinguished by a combination of the CEA level and baseline CTC count with a cutoff point of 3/per 7.5 mL, suggesting that the performance of the CEA level could be improved by combining it with the CTC marker [31].